Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention - Takeaways - MDSpire

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

  • By

  • Qiang Zhao

  • Shenwen Fu

  • Xiaokang Hu

  • Xianqing Hu

  • May 26, 2026

  • 0 min

Share

  • 1

    CTI is an independent predictor of major adverse cardiovascular events (MACE) in STEMI patients undergoing PCI.

  • 2

    The study included 618 STEMI patients, with 22.5% experiencing MACE during follow-up.

  • 3

    CTI's association with MACE was primarily driven by acute heart failure events.

  • 4

    Subgroup analysis showed consistent CTI-MACE associations regardless of diabetes status.

  • 5

    CTI integrates metabolic and inflammatory status, enhancing risk stratification in STEMI patients.

Original Source(s)

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

  • by Qiang Zhao, Shenwen Fu, Xiaokang Hu, Xianqing Hu

  • May 26, 2026

Related Content

Lipoprotein(a) and Risk of Treated Ventricular Arrhythmias in Heart Failure

Correction: Multicriteria Optimization of Language Models for Heart Failure With Preserved Ejection Fraction Symptom Detection in Spanish Electronic Health Records: Comparative Modeling Study

Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study